Matrices listed below were spiked with certain level of Anti-2019 nCoV(N) IgG and the recovery rates were calculated by comparing the measured value to the expected amount of Anti-2019 nCoV(N) IgG in samples.
Matrix
Recovery range(%)
Average(%)
serum(n=5)
89-94
92
EDTA plasma(n=5)
88-103
94
heparin plasma(n=5)
93-102
97
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Anti-2019 nCoV(N) IgG and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Sample
1:2
1:4
1:8
serum(n=5)
85-103%
87-105%
87-99%
EDTA plasma(n=5)
83-98%
94-99%
93-99%
heparin plasma(n=5)
87-93%
81-99%
86-97%
Sensitivity
< Qualitative
Notes
For Research Use Only
Applications
ELISA
Applications Notes
Anti-2019 nCoV IgG ELISA Kit allows for the in vitro quantitative determination of Anti-2019 nCoV(N) IgG concentrations in serum, plasma, tissue homogenates and other biological fluids.